{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:40:28Z","timestamp":1792640428445,"version":"4.5.0"},"reference-count":303,"publisher":"Portland Press Ltd.","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Down syndrome (DS) is the most common chromosomal abnormality and leads to intellectual disability, increased risk of cardiac defects, and an altered immune response. Individuals with DS have an extra full or partial copy of chromosome 21 (trisomy 21) and are more likely to develop early-onset Alzheimer\u2019s disease (AD) than the general population. Changes in expression of human chromosome 21 (Hsa21)-encoded genes, such as amyloid precursor protein (APP), play an important role in the pathogenesis of AD in DS (DS-AD). However, the mechanisms of DS-AD remain poorly understood. To date, several mouse models with an extra copy of genes syntenic to Hsa21 have been developed to characterise DS-AD-related phenotypes. Nonetheless, due to genetic and physiological differences between mouse and human, mouse models cannot faithfully recapitulate all features of DS-AD. Cells differentiated from human-induced pluripotent stem cells (iPSCs), isolated from individuals with genetic diseases, can be used to model disease-related cellular and molecular pathologies, including DS. In this review, we will discuss the limitations of mouse models of DS and how these can be addressed using recent advancements in modelling DS using human iPSCs and iPSC-mouse chimeras, and potential applications of iPSCs in preclinical studies for DS-AD.<\/jats:p>","DOI":"10.1042\/ns20210054","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:07:25Z","timestamp":1647943645000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cell models for Down syndrome-Alzheimer\u2019s disease research"],"prefix":"10.1042","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-9948","authenticated-orcid":false,"given":"Yixing","family":"Wu","sequence":"first","affiliation":[{"name":"U.K. Dementia Research Institute, Institute of Neurology, University College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole\u00a0R.","family":"West","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Biology Graduate Program, University of Wisconsin-Madison, Madison, WI 53705, U.S.A."},{"name":"Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-7145","authenticated-orcid":false,"given":"Anita","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, U.S.A."},{"name":"Department of Cell and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-3548","authenticated-orcid":false,"given":"Frances\u00a0K.","family":"Wiseman","sequence":"additional","affiliation":[{"name":"U.K. Dementia Research Institute, Institute of Neurology, University College London, London, U.K."},{"name":"LonDownS Consortium, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"2022041109372108600_B1","first-page":"602","article-title":"Human chromosomes in tissue cultures","volume":"248","author":"Lejeune","year":"1959","journal-title":"C. R. Hebd. Seances Acad. Sci."},{"key":"2022041109372108600_B2","first-page":"1721","article-title":"Study of somatic chromosomes from 9 mongoloid children","volume":"248","author":"Lejeune","year":"1959","journal-title":"C. R. Hebd. Seances Acad. Sci."},{"key":"2022041109372108600_B3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/35066065","article-title":"To err (meiotically) is human: the genesis of human aneuploidy","volume":"2","author":"Hassold","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"2022041109372108600_B4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mrdd.20166","article-title":"Education and children with Down syndrome: neuroscience, development, and intervention","volume":"13","author":"Fidler","year":"2007","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"2022041109372108600_B5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/35012518","article-title":"The DNA sequence of human chromosome 21","volume":"405","author":"Hattori","year":"2000","journal-title":"Nature"},{"key":"2022041109372108600_B6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nrn3314","article-title":"Down syndrome: the brain in trisomic mode","volume":"13","author":"Dierssen","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"2022041109372108600_B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2022041109372108600_B8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci."},{"key":"2022041109372108600_B9","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1176\/appi.ajp.158.10.1659","article-title":"Neuroanatomy of Down\u2019s syndrome: a high-resolution MRI study","volume":"158","author":"Pinter","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"2022041109372108600_B10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/dmcn.14260","article-title":"New approaches to studying early brain development in Down syndrome","volume":"61","author":"Baburamani","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"2022041109372108600_B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1203\/01.pdr.0000190580.88391.9a","article-title":"Biometry of face and brain in fetuses with trisomy 21","volume":"59","author":"Guihard-Costa","year":"2006","journal-title":"Pediatr. Res."},{"key":"2022041109372108600_B12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/978-1-4615-6622-9_12","volume-title":"Down Syndrome, in Normal and Altered States of Function","author":"Kemper","year":"1991"},{"key":"2022041109372108600_B13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.34.7.909","article-title":"Down\u2019s syndrome: is there a decreased population of neurons?","volume":"34","author":"Ross","year":"1984","journal-title":"Neurology"},{"key":"2022041109372108600_B14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00005072-199409000-00011","article-title":"Development of the superior temporal neocortex is anomalous in trisomy 21","volume":"53","author":"Golden","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2022041109372108600_B15","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archneurpsyc.1928.02210180080004","article-title":"The brain in mongolian idiocy: a report of ten cases","volume":"20","author":"Davidoff","year":"1928","journal-title":"Arch. Neurol. Psychiatry"},{"key":"2022041109372108600_B16","first-page":"133","article-title":"Growth and development of the brain in Down syndrome","volume":"373","author":"Becker","year":"1991","journal-title":"Prog. Clin. Biol. Res."},{"key":"2022041109372108600_B17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1212\/WNL.44.6.1039","article-title":"Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down\u2019s syndrome","volume":"44","author":"Kesslak","year":"1994","journal-title":"Neurology"},{"key":"2022041109372108600_B18","first-page":"181","article-title":"Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months","volume":"9","author":"Schmidt-Sidor","year":"1990","journal-title":"Clin. Neuropathol."},{"key":"2022041109372108600_B19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ajmg.1320370755","article-title":"Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis","volume":"37","author":"Wisniewski","year":"1990","journal-title":"Am. J. Med. Genet."},{"key":"2022041109372108600_B20","volume-title":"Pathology of mental retardation","author":"Crome","year":"1967"},{"key":"2022041109372108600_B21","article-title":"Mongolism and cretinism","volume-title":"Mongolism and cretinism","author":"Benda","year":"1946"},{"key":"2022041109372108600_B22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-0028-1091775","article-title":"The structure of the cerebral cortex in Down\u2019s syndrome: a quantitative analysis","volume":"3","author":"Colon","year":"1972","journal-title":"Neuropediatrics"},{"key":"2022041109372108600_B23","article-title":"Fact sheets","author":"Dementia","year":"2020"},{"key":"2022041109372108600_B24","doi-asserted-by":"publisher","first-page":"b158","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"2022041109372108600_B25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2022041109372108600_B26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin. Anat."},{"key":"2022041109372108600_B27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1196\/annals.1354.065","article-title":"Alzheimer\u2019s disease pathogenesis","volume":"1067","author":"Harman","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2022041109372108600_B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00221","article-title":"\u03b2-Amyloid: the key peptide in the pathogenesis of Alzheimer\u2019s disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front. Pharmacol."},{"key":"2022041109372108600_B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/alzrt107","article-title":"Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer\u2019s disease","volume":"4","author":"Weggen","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"2022041109372108600_B30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41582-019-0158-4","article-title":"Alzheimer disease risk genes: 29 and counting","volume":"15","author":"Bertram","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"2022041109372108600_B31","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"2022041109372108600_B32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"2022041109372108600_B33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"2022041109372108600_B34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"2022041109372108600_B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"2022041109372108600_B36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/exnr.1997.6777","article-title":"Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis","volume":"150","author":"Leverenz","year":"1998","journal-title":"Exp. Neurol."},{"key":"2022041109372108600_B37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2559.1988.tb02018.x","article-title":"Alzheimer\u2019s disease and Down\u2019s syndrome","volume":"13","author":"Mann","year":"1988","journal-title":"Histopathology"},{"key":"2022041109372108600_B38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"2022041109372108600_B39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jir.12074","article-title":"A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"58","author":"McCarron","year":"2014","journal-title":"J. Intellect. Disabil. Res."},{"key":"2022041109372108600_B40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(21)00129-0","article-title":"Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study","volume":"20","author":"Carmona-Iragui","year":"2021","journal-title":"Lancet Neurol."},{"key":"2022041109372108600_B41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132776","article-title":"Epilepsy in Down syndrome: a highly prevalent comorbidity","volume":"10","author":"Altuna","year":"2021","journal-title":"J. Clin. Med."},{"key":"2022041109372108600_B42","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1093\/brain\/awl203","article-title":"APP duplication is sufficient to cause early onset Alzheimer\u2019s dementia with cerebral amyloid angiopathy","volume":"129","author":"Sleegers","year":"2006","journal-title":"Brain"},{"key":"2022041109372108600_B43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"key":"2022041109372108600_B44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann. Neurol."},{"key":"2022041109372108600_B45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down Syndrome, Partial Trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"2022041109372108600_B46","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/dneu.22713","article-title":"Neuropathological correlates of amyloid PET imaging in Down syndrome","volume":"79","author":"Abrahamson","year":"2019","journal-title":"Dev. Neurobiol."},{"key":"2022041109372108600_B47","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1093\/brain\/awu173","article-title":"Cognitive functioning in relation to brain amyloid-beta in healthy adults with Down syndrome","volume":"137","author":"Hartley","year":"2014","journal-title":"Brain"},{"key":"2022041109372108600_B48","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.dadm.2019.04.006","article-title":"Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: a deep-phenotyping case report","volume":"11","author":"Mak","year":"2019","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"2022041109372108600_B49","doi-asserted-by":"publisher","first-page":"e12020","DOI":"10.1002\/dad2.12020","article-title":"Amyloid accumulation in Down syndrome measured with amyloid load","volume":"12","author":"Zammit","year":"2020","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"2022041109372108600_B50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-018-1866-3","article-title":"Patterns and severity of vascular amyloid in Alzheimer\u2019s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer\u2019s disease","volume":"136","author":"Mann","year":"2018","journal-title":"Acta Neuropathol."},{"key":"2022041109372108600_B51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/bj3550609","article-title":"The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase","volume":"355","author":"Woods","year":"2001","journal-title":"Biochem. J."},{"key":"2022041109372108600_B52","doi-asserted-by":"publisher","first-page":"828.e31","DOI":"10.1016\/j.neurobiolaging.2011.06.025","article-title":"Altered regulation of tau phosphorylation in a mouse model of down syndrome aging","volume":"33","author":"Sheppard","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"2022041109372108600_B53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer\u2019s disease phenotypes","volume":"106","author":"Garcia-Cerro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"2022041109372108600_B54","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/hmg\/dds142","article-title":"Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes","volume":"21","author":"Cossec","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B55","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1038\/s41380-020-0806-5","article-title":"Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain","volume":"26","author":"Ali\u0107","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"2022041109372108600_B56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/brain\/awq341","article-title":"Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits","volume":"134","author":"Yang","year":"2011","journal-title":"Brain"},{"key":"2022041109372108600_B57","doi-asserted-by":"publisher","first-page":"e0242236","DOI":"10.1371\/journal.pone.0242236","article-title":"The effects of Cstb duplication on APP\/amyloid-\u03b2 pathology and cathepsin B activity in a mouse model","volume":"16","author":"Wu","year":"2021","journal-title":"PLoS ONE"},{"key":"2022041109372108600_B58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","article-title":"Gene expression profiling in the adult Down syndrome brain","volume":"90","author":"Lockstone","year":"2007","journal-title":"Genomics"},{"key":"2022041109372108600_B59","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jamaneurol.2021.1893","article-title":"Association of apolipoprotein E \u025b4 allele with clinical and multimodal biomarker changes of Alzheimer disease in adults with Down syndrome","volume":"78","author":"Bejanin","year":"2021","journal-title":"JAMA Neurol."},{"key":"2022041109372108600_B60","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neurobiolaging.2006.12.013","article-title":"The impact of apolipoprotein E on dementia in persons with Down\u2019s syndrome","volume":"29","author":"Coppus","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"2022041109372108600_B61","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1192\/bjp.176.5.468","article-title":"APOE epsilon 4 influences the manifestation of Alzheimer\u2019s disease in adults with Down\u2019s syndrome","volume":"176","author":"Deb","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"2022041109372108600_B62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamaneurol.2018.3616","article-title":"Association of dementia with mortality among adults with Down syndrome older than 35 years","volume":"76","author":"Hithersay","year":"2019","journal-title":"JAMA Neurol."},{"key":"2022041109372108600_B63","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1073\/pnas.92.8.3586","article-title":"Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome)","volume":"92","author":"Hyman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neulet.2010.10.010","article-title":"Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer\u2019s disease in subjects with Down syndrome","volume":"487","author":"Patel","year":"2011","journal-title":"Neurosci. Lett."},{"key":"2022041109372108600_B65","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/gps.2039","article-title":"Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer\u2019s disease and mortality in persons with Down syndrome","volume":"23","author":"Prasher","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"2022041109372108600_B66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jppi.12042","article-title":"Intellectual disability, mild cognitive impairment, and risk for dementia","volume":"10","author":"Silverman","year":"2013","journal-title":"J. Policy Pract. Intellect. Disabil."},{"key":"2022041109372108600_B67","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-170045","article-title":"Mouse models of Alzheimer\u2019s disease","volume":"57","author":"Esquerda-Canals","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"2022041109372108600_B68","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","article-title":"Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models","volume":"22","author":"Friedman","year":"2018","journal-title":"Cell Rep."},{"key":"2022041109372108600_B69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/geno.2001.6639","article-title":"Evolutionary breakpoints on human chromosome 21","volume":"78","author":"Davisson","year":"2001","journal-title":"Genomics"},{"key":"2022041109372108600_B70","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1093\/hmg\/ddl179","article-title":"New techniques to understand chromosome dosage: mouse models of aneuploidy","volume":"15","author":"Tybulewicz","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnbeh.2015.00268","article-title":"Dissecting Alzheimer disease in Down syndrome using mouse models","volume":"9","author":"Choong","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"2022041109372108600_B72","first-page":"263","article-title":"Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome","volume":"360","author":"Davisson","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"2022041109372108600_B73","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","article-title":"Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome","volume":"22","author":"Duchon","year":"2011","journal-title":"Mamm. Genome"},{"key":"2022041109372108600_B74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"key":"2022041109372108600_B75","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","article-title":"Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome","volume":"93","author":"Holtzman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"2022041109372108600_B77","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41598-017-00682-y","article-title":"Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice","volume":"7","author":"Yin","year":"2017","journal-title":"Sci. Rep."},{"key":"2022041109372108600_B78","doi-asserted-by":"publisher","first-page":"e0152471","DOI":"10.1371\/journal.pone.0152471","article-title":"An anti-\u03b2-amyloid vaccine for treating cognitive deficits in a mouse model of Down syndrome","volume":"11","author":"Belichenko","year":"2016","journal-title":"PLoS ONE"},{"key":"2022041109372108600_B79","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.046243","article-title":"Longitudinal neuroanatomical and behavioral analyses show phenotypic drift and variability in the Ts65Dn mouse model of Down syndrome","volume":"13","author":"Shaw","year":"2020","journal-title":"Dis. Model Mech."},{"key":"2022041109372108600_B80","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/hmg\/ddm086","article-title":"Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities","volume":"16","author":"Li","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B81","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1534\/genetics.108.092312","article-title":"Inducing segmental aneuploid mosaicism in the mouse through targeted asymmetric sister chromatid event of recombination","volume":"180","author":"Duchon","year":"2008","journal-title":"Genetics"},{"key":"2022041109372108600_B83","doi-asserted-by":"publisher","first-page":"e1002724","DOI":"10.1371\/journal.pgen.1002724","article-title":"The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model","volume":"8","author":"Raveau","year":"2012","journal-title":"PLoS Genet."},{"key":"2022041109372108600_B84","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1038\/s41598-021-85062-3","article-title":"Genetic dissection of down syndrome-associated alterations in APP\/amyloid-\u03b2 biology using mouse models","volume":"11","author":"Tosh","year":"2021","journal-title":"Sci. Rep."},{"key":"2022041109372108600_B85","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13024-020-00399-z","article-title":"Modeling the \u03b2-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease","volume":"15","author":"Serneels","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"2022041109372108600_B86","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1038\/s41467-021-22624-z","article-title":"Generation of a humanized A\u03b2 expressing mouse demonstrating aspects of Alzheimer\u2019s disease-like pathology","volume":"12","author":"Baglietto-Vargas","year":"2021","journal-title":"Nat. Commun."},{"key":"2022041109372108600_B87","doi-asserted-by":"publisher","first-page":"e60482","DOI":"10.1371\/journal.pone.0060482","article-title":"Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down Syndrome","volume":"8","author":"Gribble","year":"2013","journal-title":"PLoS ONE"},{"key":"2022041109372108600_B88","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1126\/science.1114535","article-title":"An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes","volume":"309","author":"Doherty","year":"2005","journal-title":"Science"},{"key":"2022041109372108600_B89","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/brain\/awy159","article-title":"Trisomy of human chromosome 21 enhances amyloid-\u03b2 deposition independently of an extra copy of APP","volume":"141","author":"Wiseman","year":"2018","journal-title":"Brain"},{"key":"2022041109372108600_B90","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1371\/journal.pgen.0020050","article-title":"Understanding the basis for Down syndrome phenotypes","volume":"2","author":"Roper","year":"2006","journal-title":"PLoS Genet."},{"key":"2022041109372108600_B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.56223","article-title":"A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21","volume":"9","author":"Kazuki","year":"2020","journal-title":"eLife"},{"key":"2022041109372108600_B92","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"2022041109372108600_B93","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ajhg.2018.10.009","article-title":"Human models are needed for studying human neurodevelopmental disorders","volume":"103","author":"Zhao","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"2022041109372108600_B94","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"2022041109372108600_B95","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/emph\/eow014","article-title":"Mouse models of human disease: an evolutionary perspective","volume":"2016","author":"Perlman","year":"2016","journal-title":"Evol. Med. Public Health"},{"key":"2022041109372108600_B96","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"2022041109372108600_B97","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature13992","article-title":"A comparative encyclopedia of DNA elements in the mouse genome","volume":"515","author":"Yue","year":"2014","journal-title":"Nature"},{"key":"2022041109372108600_B98","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","article-title":"Conserved cell types with divergent features in human versus mouse cortex","volume":"573","author":"Hodge","year":"2019","journal-title":"Nature"},{"key":"2022041109372108600_B99","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1038\/s41467-021-24232-3","article-title":"Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"2022041109372108600_B100","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cell.2019.11.010","article-title":"Cross-species single-cell analysis reveals divergence of the primate microglia program","volume":"179","author":"Geirsdottir","year":"2019","journal-title":"Cell"},{"key":"2022041109372108600_B101","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0888-7543(03)00035-1","article-title":"Global up-regulation of chromosome 21 gene expression in the developing down syndrome brain","volume":"81","author":"Mao","year":"2003","journal-title":"Genomics"},{"key":"2022041109372108600_B102","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2016.01.042","article-title":"Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination","volume":"89","author":"Olmos-Serrano","year":"2016","journal-title":"Neuron"},{"key":"2022041109372108600_B103","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF00687256","article-title":"Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain","volume":"77","author":"Motte","year":"1989","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"2022041109372108600_B104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid b-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"2022041109372108600_B105","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ana.410370305","article-title":"Amyloid protein A deposition A 42 43 precedes A 40 in down Syndrome","volume":"37","author":"Iwatsubo","year":"1995","journal-title":"Ann. Neurol."},{"key":"2022041109372108600_B106","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","article-title":"Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome: quantitative regional analysis and comparison with Alzheimer\u2019s disease","volume":"52","author":"Hof","year":"1995","journal-title":"Arch. Neurol."},{"key":"2022041109372108600_B107","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neurobiolaging.2017.03.005","article-title":"Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan","volume":"54","author":"LeVine","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"2022041109372108600_B108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s004010050968","article-title":"Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology","volume":"97","author":"Sadowski","year":"1999","journal-title":"Acta Neuropathol."},{"key":"2022041109372108600_B109","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease","volume":"16","author":"G\u00f3mez-Isla","year":"1996","journal-title":"J. Neurosci."},{"key":"2022041109372108600_B110","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.3233\/JAD-2010-100351","article-title":"Systemic mitochondrial dysfunction and the etiology of Alzheimer\u2019s disease and down syndrome dementia","volume":"20","author":"Coskun","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"2022041109372108600_B111","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"2022041109372108600_B112","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","article-title":"Down syndrome individuals with Alzheimer\u2019s disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer\u2019s disease","volume":"36","author":"Wilcock","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"2022041109372108600_B113","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1093\/brain\/awaa326","article-title":"Evolution of neuroinflammation across the lifespan of individuals with Down syndrome","volume":"143","author":"Flores-Aguilar","year":"2020","journal-title":"Brain"},{"key":"2022041109372108600_B114","doi-asserted-by":"publisher","first-page":"e12113","DOI":"10.1002\/dad2.12113","article-title":"Distribution of microglial phenotypes as a function of age and Alzheimer\u2019s disease neuropathology in the brains of people with Down syndrome","volume":"12","author":"Martini","year":"2020","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"2022041109372108600_B115","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jalz.2016.05.001","article-title":"An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation","volume":"12","author":"Iulita","year":"2016","journal-title":"Alzheimers Dement."},{"key":"2022041109372108600_B116","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"2022041109372108600_B117","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1086\/520000","article-title":"Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes","volume":"81","author":"A\u00eft Yahya-Graison","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"2022041109372108600_B118","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/gb-2005-6-13-r107","article-title":"Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart","volume":"6","author":"Mao","year":"2005","journal-title":"Genome Biol."},{"key":"2022041109372108600_B119","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fgene.2018.00125","article-title":"Integrated quantitative transcriptome maps of human trisomy 21 tissues and cells","volume":"9","author":"Pelleri","year":"2018","journal-title":"Front. Genet."},{"key":"2022041109372108600_B120","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/00005072-199811000-00012","article-title":"Quantification of modified amyloid \u03b2 peptides in Alzheimer disease and Down syndrome brains","volume":"57","author":"Hosoda","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2022041109372108600_B121","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1093\/hmg\/11.26.3249","article-title":"Transcriptome analysis of human autosomal trisomy","volume":"11","author":"FitzPatrick","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/alz.12463","article-title":"Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model","author":"Sawa","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"47","key":"2022041109372108600_B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2114326118","article-title":"Altered cell and RNA isoform diversity in aging Down syndrome brains","volume":"118","author":"Palmer","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B124","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1089\/bio.2019.0138","article-title":"The barriers and motivators to using human tissues for research: the views of UK-based biomedical researchers","volume":"18","author":"Lawrence","year":"2020","journal-title":"Biopreserv. Biobank."},{"key":"2022041109372108600_B125","article-title":"Realising the potential of stratified medicine","year":"2013"},{"key":"2022041109372108600_B126","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10571-019-00653-z","article-title":"Recent expansions on cellular models to uncover the scientific barriers towards drug development for Alzheimer\u2019s disease","volume":"39","author":"Dubey","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"2022041109372108600_B127","first-page":"1501","article-title":"GABA (A) receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome","volume":"223","author":"Milenkovic","year":"2018","journal-title":"Brain Struct. Funct."},{"key":"2022041109372108600_B128","doi-asserted-by":"publisher","first-page":"e0186636","DOI":"10.1371\/journal.pone.0186636","article-title":"In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells","volume":"12","author":"Krishtal","year":"2017","journal-title":"PLoS ONE"},{"key":"2022041109372108600_B129","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00702-005-0318-0","article-title":"Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells","volume":"113","author":"Matsumoto","year":"2006","journal-title":"J. Neural Transm."},{"key":"2022041109372108600_B130","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/JEN.S25100","article-title":"A simple model to study tau pathology","volume":"10","author":"Houck","year":"2016","journal-title":"J. Exp. Neurosci."},{"key":"2022041109372108600_B131","doi-asserted-by":"publisher","first-page":"11202","DOI":"10.1093\/nar\/gky754","article-title":"DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2022041109372108600_B132","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.4161\/cc.29104","article-title":"The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation","volume":"13","author":"Soppa","year":"2014","journal-title":"Cell Cycle"},{"key":"2022041109372108600_B133","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1006\/bbrc.1998.8336","article-title":"The presenilin 1 mutation (M146V) linked to familial Alzheimer\u2019s disease attenuates the neuronal differentiation of NTera 2 cells","volume":"244","author":"Tokuhiro","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2022041109372108600_B134","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1172\/JCI2029","article-title":"Human blood-brain barrier receptors for Alzheimer\u2019s 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer","volume":"102","author":"Mackic","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2022041109372108600_B135","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10616-010-9313-x","article-title":"Characterization and use of human brain microvascular endothelial cells to examine \u03b2-amyloid exchange in the blood-brain barrier","volume":"62","author":"Bachmeier","year":"2010","journal-title":"Cytotechnology"},{"key":"2022041109372108600_B136","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12974-016-0670-z","article-title":"HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease","volume":"13","author":"Festoff","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"2022041109372108600_B137","doi-asserted-by":"publisher","first-page":"e91003","DOI":"10.1371\/journal.pone.0091003","article-title":"A novel blood-brain barrier co-culture system for drug targeting of Alzheimer\u2019s disease: establishment by using acitretin as a model drug","volume":"9","author":"Freese","year":"2014","journal-title":"PLoS ONE"},{"key":"2022041109372108600_B138","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.2147\/IJN.S132472","article-title":"Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin","volume":"12","author":"Kuo","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"2022041109372108600_B139","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/21691401.2018.1436552","article-title":"RIP140\/PGC-1\u03b1 axis involved in vitamin A-induced neural differentiation by increasing mitochondrial function","volume":"46","author":"Mu","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"2022041109372108600_B140","doi-asserted-by":"publisher","first-page":"1600530","DOI":"10.1002\/mnfr.201600530","article-title":"Lycopene inhibits regulator of calcineurin 1-mediated apoptosis by reducing oxidative stress and down-regulating Nucling in neuronal cells","volume":"61","author":"Lim","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"2022041109372108600_B141","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer\u2019s disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"2022041109372108600_B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2014723118","article-title":"Consequences of aneuploidy in human fibroblasts with trisomy 21","volume":"118","author":"Hwang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B143","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbadis.2013.10.014","article-title":"Decreased cell proliferation and higher oxidative stress in fibroblasts from Down Syndrome fetuses. Preliminary study","volume":"1842","author":"Gimeno","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2022041109372108600_B144","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/hmg\/dds529","article-title":"Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects","volume":"22","author":"Piccoli","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B145","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2353\/ajpath.2008.071053","article-title":"Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects","volume":"173","author":"Cataldo","year":"2008","journal-title":"Am. J. Pathol."},{"key":"2022041109372108600_B146","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","article-title":"mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy","volume":"10","author":"Bordi","year":"2019","journal-title":"Cell Death Dis."},{"key":"2022041109372108600_B147","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","article-title":"Lysosomal dysfunction in Down syndrome is APP-dependent and mediated by APP-\u03b2CTF (C99)","volume":"39","author":"Jiang","year":"2019","journal-title":"J. Neurosci."},{"key":"2022041109372108600_B148","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2017.10.001","article-title":"Dysfunction of autophagy and endosomal-lysosomal pathways: roles in pathogenesis of Down syndrome and Alzheimer\u2019s disease","volume":"114","author":"Colacurcio","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"2022041109372108600_B149","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1073\/pnas.0908953107","article-title":"Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B150","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/378776a0","article-title":"Apoptosis and increased generation of reactive oxygen species in Down\u2019s syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nature"},{"key":"2022041109372108600_B151","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","article-title":"Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down\u2019s syndrome","volume":"33","author":"Busciglio","year":"2002","journal-title":"Neuron"},{"key":"2022041109372108600_B152","doi-asserted-by":"publisher","DOI":"10.3791\/2681","article-title":"Generation of neural stem cells from discarded human fetal cortical tissue","author":"Lu","year":"2011","journal-title":"J. Vis Exp."},{"key":"2022041109372108600_B153","first-page":"500","article-title":"[Experimental study on growth, proliferation and differentiation of neural stem cell from subventricular zone of human fetal brain at different gestational age]","volume":"44","author":"Yin","year":"2006","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2022041109372108600_B154","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000236899","article-title":"A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells","volume":"31","author":"Bhattacharyya","year":"2009","journal-title":"Dev. Neurosci."},{"key":"2022041109372108600_B155","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/hmg\/ddm322","article-title":"Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury","volume":"17","author":"Esposito","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B156","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrm.2015.27","article-title":"Pluripotent stem cells in disease modelling and drug discovery","volume":"17","author":"Avior","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2022041109372108600_B157","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/cells9102193","article-title":"Stem cell-based disease modeling and cell therapy","volume":"9","author":"Bai","year":"2020","journal-title":"Cells"},{"key":"2022041109372108600_B158","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1566523211313020004","article-title":"Modelling human disease with pluripotent stem cells","volume":"13","author":"Siller","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"2022041109372108600_B159","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","article-title":"Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery","volume":"26","author":"Sharma","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B160","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.jmedchem.5b00789","article-title":"Patient-specific induced pluripotent stem cells for disease modeling and phenotypic drug discovery","volume":"59","author":"Tang","year":"2016","journal-title":"J. Med. Chem."},{"key":"2022041109372108600_B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2015.00002","article-title":"Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery","volume":"3","author":"Singh","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"2022041109372108600_B162","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.stem.2009.08.010","article-title":"Pluripotent stem cells and disease modeling","volume":"5","author":"Colman","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B163","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12035-014-8867-6","article-title":"Induced pluripotent stem cells for disease modeling and drug discovery in neurodegenerative diseases","volume":"52","author":"Cao","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"2022041109372108600_B164","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1093\/hmg\/ddr336","article-title":"Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises","volume":"20","author":"Marchetto","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B165","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2008.02.010","article-title":"Stem cells and drug discovery: the beginning of a new era?","volume":"132","author":"Rubin","year":"2008","journal-title":"Cell"},{"key":"2022041109372108600_B166","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrd3577","article-title":"Induced pluripotent stem cells \u2014 opportunities for disease modelling and drug discovery","volume":"10","author":"Grskovic","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"2022041109372108600_B167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25082000","article-title":"Induced pluripotent stem cell (iPSC)-based neurodegenerative disease models for phenotype recapitulation and drug screening","volume":"25","author":"Chang","year":"2020","journal-title":"Molecules"},{"key":"2022041109372108600_B168","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"2022041109372108600_B169","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/stem.483","article-title":"Human embryonic stem cells as models for aneuploid chromosomal syndromes","volume":"28","author":"Biancotti","year":"2010","journal-title":"Stem Cells"},{"key":"2022041109372108600_B170","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.stemcr.2016.08.003","article-title":"Molecular characterization of down syndrome embryonic stem cells reveals a role for RUNX1 in neural differentiation","volume":"7","author":"Halevy","year":"2016","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B171","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.scr.2016.02.003","article-title":"Derivation of Trisomy 21 affected human embryonic stem cell line Genea053","volume":"16","author":"Dumevska","year":"2016","journal-title":"Stem Cell Res."},{"key":"2022041109372108600_B172","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ajhg.2008.08.012","article-title":"DYRK1A-dosage imbalance perturbs NRSF\/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome","volume":"83","author":"Canzonetta","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"2022041109372108600_B173","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/humrep\/deg143","article-title":"Human embryonic stem cells: research, ethics and policy","volume":"18","author":"Wert","year":"2003","journal-title":"Hum. Reprod."},{"key":"2022041109372108600_B174","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1210\/er.2008-0031","article-title":"Ethical issues in stem cell research","volume":"30","author":"Lo","year":"2009","journal-title":"Endocr. Rev."},{"key":"2022041109372108600_B175","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/scrt474","article-title":"Ethical issues in stem cell research and therapy","volume":"5","author":"King","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"2022041109372108600_B176","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2022041109372108600_B177","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"2022041109372108600_B178","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nprot.2008.92","article-title":"Generation of human-induced pluripotent stem cells","volume":"3","author":"Park","year":"2008","journal-title":"Nat. Protoc."},{"key":"2022041109372108600_B179","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"2022041109372108600_B180","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mcn.2015.11.010","article-title":"Modeling Alzheimer\u2019s disease with human induced pluripotent stem (iPS) cells","volume":"73","author":"Mungenast","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"2022041109372108600_B181","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-017-0268-4","article-title":"Stem cell models of Alzheimer\u2019s disease: progress and challenges","volume":"9","author":"Arber","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"2022041109372108600_B182","doi-asserted-by":"publisher","first-page":"104503","DOI":"10.1016\/j.nbd.2019.104503","article-title":"Modeling Alzheimer\u2019s disease with human iPS cells: advancements, lessons, and applications","volume":"130","author":"Essayan-Perez","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"2022041109372108600_B183","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/bs.pbr.2019.10.003","article-title":"Modeling Down syndrome in cells: from stem cells to organoids","volume":"251","author":"Gough","year":"2020","journal-title":"Prog. Brain Res."},{"key":"2022041109372108600_B184","first-page":"1183","article-title":"[Progress of research on induced pluripotent stem cell models for Down syndrome]","volume":"37","author":"Zhang","year":"2020","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"2022041109372108600_B185","doi-asserted-by":"publisher","first-page":"54","DOI":"10.46582\/jsrm.1202009","article-title":"Induced pluripotent stem cells as a cellular model for studying Down Syndrome","volume":"12","author":"Brigida","year":"2016","journal-title":"J. Stem Cells Regen. Med."},{"key":"2022041109372108600_B186","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","article-title":"Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells","volume":"20","author":"Yagi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B187","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"2022041109372108600_B188","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1007\/s12035-018-1336-x","article-title":"Modeling Alzheimer\u2019s disease by induced pluripotent stem cells carrying APP D678H mutation","volume":"56","author":"Chang","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"2022041109372108600_B189","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer\u2019s disease with iPSCs reveals stress phenotypes associated with intracellular A\u03b2 and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B190","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1326-9-3","article-title":"Stem cell derived basal forebrain cholinergic neurons from Alzheimer\u2019s disease patients are more susceptible to cell death","volume":"9","author":"Duan","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"2022041109372108600_B191","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13024-020-00411-6","article-title":"Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease","volume":"15","author":"Ma","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"2022041109372108600_B192","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3390\/cells9092018","article-title":"A simple differentiation protocol for generation of induced pluripotent stem cell-derived basal forebrain-like cholinergic neurons for Alzheimer\u2019s disease and frontotemporal dementia disease modeling","volume":"9","author":"Mu\u00f1oz","year":"2020","journal-title":"Cells"},{"key":"2022041109372108600_B193","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fncel.2020.00151","article-title":"A three-dimensional Alzheimer\u2019s disease cell culture model using iPSC-derived neurons carrying A246E mutation in PSEN1","volume":"14","author":"Hern\u00e1ndez-Sapi\u00e9ns","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"2022041109372108600_B194","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/gm265","article-title":"Capturing Alzheimer\u2019s disease genomes with induced pluripotent stem cells: prospects and challenges","volume":"3","author":"Israel","year":"2011","journal-title":"Genome Med."},{"key":"2022041109372108600_B195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8897494","article-title":"Reconstruction of Alzheimer\u2019s disease cell model in vitro via extracted peripheral blood molecular cells from a sporadic patient","volume":"2020","author":"Liu","year":"2020","journal-title":"Stem Cells Int."},{"key":"2022041109372108600_B196","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.stem.2021.04.004","article-title":"Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer\u2019s patients","volume":"28","author":"Mertens","year":"2021","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B197","doi-asserted-by":"publisher","first-page":"1112.e9","DOI":"10.1016\/j.celrep.2019.01.023","article-title":"REST and neural gene network dysregulation in iPSC models of Alzheimer\u2019s disease","volume":"26","author":"Meyer","year":"2019","journal-title":"Cell Rep."},{"key":"2022041109372108600_B198","doi-asserted-by":"publisher","first-page":"85.e8","DOI":"10.1016\/j.devcel.2018.06.005","article-title":"3D culture method for Alzheimer\u2019s disease modeling reveals interleukin-4 rescues A\u03b242-induced loss of human neural stem cell plasticity","volume":"46","author":"Papadimitriou","year":"2018","journal-title":"Dev. Cell"},{"key":"2022041109372108600_B199","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer\u2019s disease with iPSC-derived brain cells","volume":"25","author":"Penney","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"2022041109372108600_B200","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2015.10.005","article-title":"Induced pluripotent stem cells as a discovery tool for Alzheimer\u2019s disease","volume":"1656","author":"Sullivan","year":"2017","journal-title":"Brain Res."},{"key":"2022041109372108600_B201","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.celrep.2013.10.018","article-title":"The Presenilin-1 \u0394E9 mutation results in reduced \u03b3-secretase activity, but not total loss of PS1 function, in isogenic human stem cells","volume":"5","author":"Woodruff","year":"2013","journal-title":"Cell Rep."},{"key":"2022041109372108600_B202","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2020.00328","article-title":"In vitro models of neurodegenerative diseases","volume":"8","author":"Slanzi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"2022041109372108600_B203","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"2022041109372108600_B204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI135763","article-title":"DSCAM\/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome","volume":"131","author":"Tang","year":"2021","journal-title":"J. Clin. Invest."},{"key":"2022041109372108600_B205","doi-asserted-by":"publisher","first-page":"294.e3","DOI":"10.1016\/j.devcel.2019.12.015","article-title":"Silencing trisomy 21 with XIST in neural stem cells promotes neuronal differentiation","volume":"52","author":"Czermi\u0144ski","year":"2020","journal-title":"Dev. Cell"},{"key":"2022041109372108600_B206","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/hmg\/ddaa003","article-title":"Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics","volume":"29","author":"Ponroy Bally","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"2022041109372108600_B207","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13148-019-0803-1","article-title":"DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors","volume":"12","author":"Laan","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"2022041109372108600_B208","doi-asserted-by":"publisher","first-page":"908.e8","DOI":"10.1016\/j.stem.2019.04.014","article-title":"OLIG2 Drives abnormal neurodevelopmental phenotypes in human iPSC-based organoid and chimeric mouse models of Down Syndrome","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B209","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1007\/s12035-019-1585-3","article-title":"Transcriptome and proteome profiling of neural induced pluripotent stem cells from individuals with Down Syndrome disclose dynamic dysregulations of key pathways and cellular functions","volume":"56","author":"Sobol","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"2022041109372108600_B210","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1038\/s41467-018-07630-y","article-title":"Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro","volume":"9","author":"Chiang","year":"2018","journal-title":"Nat. Commun."},{"key":"2022041109372108600_B211","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau1810","article-title":"In vivo modeling of human neuron dynamics and Down syndrome","volume":"362","author":"Real","year":"2018","journal-title":"Science"},{"key":"2022041109372108600_B212","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","article-title":"Modeling amyloid beta and tau pathology in human cerebral organoids","volume":"23","author":"Gonzalez","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"2022041109372108600_B213","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.stemcr.2018.05.004","article-title":"The impact of APP on Alzheimer-like pathogenesis and gene expression in Down Syndrome iPSC-derived neurons","volume":"11","author":"Ovchinnikov","year":"2018","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B214","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1007\/s12035-017-0818-6","article-title":"Down Syndrome iPSC-derived astrocytes impair neuronal synaptogenesis and the mTOR pathway in vitro","volume":"55","author":"Araujo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"2022041109372108600_B215","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1038\/s41598-017-03519-w","article-title":"Enhanced derivation of human pluripotent stem cell-derived cortical glutamatergic neurons by a small molecule","volume":"7","author":"Cao","year":"2017","journal-title":"Sci. Rep."},{"key":"2022041109372108600_B216","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jneumeth.2016.03.017","article-title":"Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells","volume":"266","author":"Hu","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"2022041109372108600_B217","doi-asserted-by":"publisher","first-page":"8744","DOI":"10.1038\/srep08744","article-title":"N-butylidenephthalide attenuates Alzheimer\u2019s disease-like cytopathy in Down Syndrome induced pluripotent stem cell-derived neurons","volume":"5","author":"Chang","year":"2015","journal-title":"Sci. Rep."},{"key":"2022041109372108600_B218","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/stem.1968","article-title":"Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration","volume":"33","author":"Murray","year":"2015","journal-title":"Stem Cells"},{"key":"2022041109372108600_B219","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/ncomms5430","article-title":"Role of astroglia in Down\u2019s syndrome revealed by patient-derived human-induced pluripotent stem cells","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"2022041109372108600_B220","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/emmm.201302848","article-title":"Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21","volume":"6","author":"Hibaoui","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"2022041109372108600_B221","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nature12394","article-title":"Translating dosage compensation to trisomy 21","volume":"500","author":"Jiang","year":"2013","journal-title":"Nature"},{"key":"2022041109372108600_B222","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/stem.1297","article-title":"Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology","volume":"31","author":"Briggs","year":"2013","journal-title":"Stem Cells"},{"key":"2022041109372108600_B223","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.yexcr.2012.09.017","article-title":"Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells","volume":"319","author":"Lu","year":"2013","journal-title":"Exp. Cell. Res."},{"key":"2022041109372108600_B224","doi-asserted-by":"publisher","first-page":"124ra29","DOI":"10.1126\/scitranslmed.3003771","article-title":"A human stem cell model of early Alzheimer\u2019s disease pathology in Down syndrome","volume":"4","author":"Shi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"2022041109372108600_B225","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.stemcr.2018.02.001","article-title":"Modeling Down Syndrome with patient iPSCs reveals cellular and migration deficits of GABAergic neurons","volume":"10","author":"Huo","year":"2018","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B226","doi-asserted-by":"publisher","first-page":"9962","DOI":"10.1073\/pnas.1216575110","article-title":"Deficits in human trisomy 21 iPSCs and neurons","volume":"110","author":"Weick","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B227","doi-asserted-by":"publisher","first-page":"17567","DOI":"10.1073\/pnas.1215468109","article-title":"Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells","volume":"109","author":"Maclean","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B228","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/scrt105","article-title":"Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome","volume":"3","author":"Mou","year":"2012","journal-title":"Stem Cell Res. Ther."},{"key":"2022041109372108600_B229","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.stem.2012.08.004","article-title":"Trisomy correction in Down syndrome induced pluripotent stem cells","volume":"11","author":"Li","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02242-7","article-title":"A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome","volume":"4","author":"Kawatani","year":"2021","journal-title":"Commun. Biol."},{"key":"2022041109372108600_B231","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41374-019-0230-0","article-title":"Autonomous trisomic rescue of Down syndrome cells","volume":"99","author":"Inoue","year":"2019","journal-title":"Lab. Invest."},{"key":"2022041109372108600_B232","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ajmg.a.36861","article-title":"Mosaicism for trisomy 21: a review","volume":"167","author":"Papavassiliou","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"2022041109372108600_B233","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ajmg.a.32729","article-title":"The phenotype of persons having mosaicism for trisomy 21\/Down syndrome reflects the percentage of trisomic cells present in different tissues","volume":"149A","author":"Papavassiliou","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"2022041109372108600_B234","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.gdata.2014.07.006","article-title":"Data in brief: transcriptome analysis of induced pluripotent stem cells from monozygotic twins discordant for trisomy 21","volume":"2","author":"Hibaoui","year":"2014","journal-title":"Genom. Data"},{"key":"2022041109372108600_B235","doi-asserted-by":"publisher","first-page":"e0194581","DOI":"10.1371\/journal.pone.0194581","article-title":"Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21","volume":"13","author":"Gonzales","year":"2018","journal-title":"PLoS ONE"},{"key":"2022041109372108600_B236","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.stem.2011.07.002","article-title":"Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions","volume":"9","author":"Ambasudhan","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B237","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1567205012999151021102914","article-title":"The link between Alzheimer\u2019s disease and Down syndrome. A historical perspective","volume":"13","author":"Salehi","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"2022041109372108600_B238","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/alz.12112","article-title":"Further understanding the connection between Alzheimer\u2019s disease and Down syndrome","volume":"16","author":"Snyder","year":"2020","journal-title":"Alzheimers Dement."},{"key":"2022041109372108600_B239","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer\u2019s disease: common pathways, common goals","volume":"11","author":"Hartley","year":"2015","journal-title":"Alzheimers Dement."},{"key":"2022041109372108600_B240","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.7506.1","article-title":"The importance of understanding individual differences in Down syndrome","volume":"5","author":"Karmiloff-Smith","year":"2016","journal-title":"F1000Res."},{"key":"2022041109372108600_B241","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-016-0106-3","article-title":"Induced pluripotent stem cells in Alzheimer\u2019s disease: applications for disease modeling and cell-replacement therapy","volume":"11","author":"Yang","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"2022041109372108600_B242","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3233\/JAD-160945","article-title":"Neurons derived from induced pluripotent stem cells of patients with Down Syndrome reproduce early stages of Alzheimer\u2019s disease type pathology in vitro","volume":"56","author":"Dashinimaev","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"2022041109372108600_B243","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000493018","article-title":"Advances and current challenges associated with the use of human induced pluripotent stem cells in modeling neurodegenerative disease","volume":"205","author":"Berry","year":"2018","journal-title":"Cells Tissues Organs"},{"key":"2022041109372108600_B244","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"2022041109372108600_B245","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.biomaterials.2013.11.028","article-title":"A 3D Alzheimer\u2019s disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"2022041109372108600_B246","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nprot.2015.065","article-title":"A 3D human neural cell culture system for modeling Alzheimer\u2019s disease","volume":"10","author":"Kim","year":"2015","journal-title":"Nat. Protoc."},{"key":"2022041109372108600_B247","doi-asserted-by":"publisher","first-page":"e0161969","DOI":"10.1371\/journal.pone.0161969","article-title":"Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer\u2019s disease phenotypes","volume":"11","author":"Raja","year":"2016","journal-title":"PLoS ONE"},{"key":"2022041109372108600_B248","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","article-title":"A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease","volume":"21","author":"Park","year":"2018","journal-title":"Nat. Neurosci."},{"key":"2022041109372108600_B249","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1038\/s41598-019-39919-3","article-title":"Synchrony and asynchrony between an epigenetic clock and developmental timing","volume":"9","author":"Hoshino","year":"2019","journal-title":"Sci. Rep."},{"key":"2022041109372108600_B250","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/acel.12325","article-title":"Accelerated epigenetic aging in Down syndrome","volume":"14","author":"Horvath","year":"2015","journal-title":"Aging Cell"},{"key":"2022041109372108600_B251","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"2022041109372108600_B252","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"key":"2022041109372108600_B253","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.stem.2011.11.015","article-title":"Induced neuronal cells: how to make and define a neuron","volume":"9","author":"Yang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B254","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.stemcr.2014.05.020","article-title":"Generation of induced neuronal cells by the single reprogramming factor ASCL1","volume":"3","author":"Chanda","year":"2014","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B255","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1073\/pnas.1105135108","article-title":"Direct conversion of human fibroblasts to dopaminergic neurons","volume":"108","author":"Pfisterer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B256","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature10284","article-title":"Direct generation of functional dopaminergic neurons from mouse and human fibroblasts","volume":"476","author":"Caiazzo","year":"2011","journal-title":"Nature"},{"key":"2022041109372108600_B257","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature10323","article-title":"MicroRNA-mediated conversion of human fibroblasts to neurons","volume":"476","author":"Yoo","year":"2011","journal-title":"Nature"},{"key":"2022041109372108600_B258","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1073\/pnas.1303829110","article-title":"Generation of induced neurons via direct conversion in vivo","volume":"110","author":"Torper","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2022041109372108600_B259","doi-asserted-by":"publisher","first-page":"e52069","DOI":"10.7554\/eLife.52069","article-title":"Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model","volume":"9","author":"Lee","year":"2020","journal-title":"eLife"},{"key":"2022041109372108600_B260","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.stem.2011.07.014","article-title":"Conversion of mouse and human fibroblasts into functional spinal motor neurons","volume":"9","author":"Son","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B261","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2011.09.002","article-title":"Direct lineage conversion of terminally differentiated hepatocytes to functional neurons","volume":"9","author":"Marro","year":"2011","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B262","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-genet-120417-031534","article-title":"Aging in a dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases","volume":"52","author":"Mertens","year":"2018","journal-title":"Annu. Rev. Genet."},{"key":"2022041109372108600_B263","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/mp.2015.161","article-title":"Generation of functional human serotonergic neurons from fibroblasts","volume":"21","author":"Vadodaria","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"2022041109372108600_B264","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/ncomms3183","article-title":"Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons","volume":"4","author":"Liu","year":"2013","journal-title":"Nat. Commun."},{"key":"2022041109372108600_B265","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nn.3887","article-title":"Selective conversion of fibroblasts into peripheral sensory neurons","volume":"18","author":"Blanchard","year":"2015","journal-title":"Nat. Neurosci."},{"key":"2022041109372108600_B266","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","article-title":"Induction of human neuronal cells by defined transcription factors","volume":"476","author":"Pang","year":"2011","journal-title":"Nature"},{"key":"2022041109372108600_B267","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41419-018-0891-4","article-title":"Transdifferentiation: a new promise for neurodegenerative diseases","volume":"9","author":"Mollinari","year":"2018","journal-title":"Cell Death Dis."},{"key":"2022041109372108600_B268","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s11064-021-03282-5","article-title":"Direct reprogramming of somatic cells to neurons: pros and cons of chemical approach","volume":"46","author":"Mollinari","year":"2021","journal-title":"Neurochem. Res."},{"key":"2022041109372108600_B269","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jnr.24615","article-title":"The application of in vitro-derived human neurons in neurodegenerative disease modeling","volume":"99","author":"D\u2019Souza","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"2022041109372108600_B270","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.stemcr.2021.11.015","article-title":"Making neurons, made easy: the use of Neurogenin-2 in neuronal differentiation","volume":"17","author":"Hulme","year":"2022","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B271","doi-asserted-by":"publisher","first-page":"3402.e9","DOI":"10.1016\/j.neuron.2021.08.003","article-title":"Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors","volume":"109","author":"Lagomarsino","year":"2021","journal-title":"Neuron"},{"key":"2022041109372108600_B272","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","article-title":"Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects","volume":"17","author":"Mertens","year":"2015","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B273","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.stemcr.2017.08.019","article-title":"Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening","volume":"9","author":"Wang","year":"2017","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B274","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41380-022-01454-5","article-title":"APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer\u2019s pathology in trisomy 21 neurons","author":"Wu","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"2022041109372108600_B275","doi-asserted-by":"publisher","first-page":"14047","DOI":"10.1038\/s41598-020-70362-x","article-title":"4-Phenylbutyrate ameliorates apoptotic neural cell death in Down syndrome by reducing protein aggregates","volume":"10","author":"Hirata","year":"2020","journal-title":"Sci. Rep."},{"key":"2022041109372108600_B276","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1365-2141.1998.00980.x","article-title":"Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain","volume":"103","author":"Goldman","year":"1998","journal-title":"Br. J. Haematol."},{"key":"2022041109372108600_B277","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nn.2600","article-title":"Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome","volume":"13","author":"Chakrabarti","year":"2010","journal-title":"Nat. Neurosci."},{"key":"2022041109372108600_B278","doi-asserted-by":"publisher","first-page":"1066.e8","DOI":"10.1016\/j.neuron.2017.02.001","article-title":"Hallmarks of Alzheimer\u2019s disease in stem-cell-derived human neurons transplanted into mouse brain","volume":"93","author":"Espuny-Camacho","year":"2017","journal-title":"Neuron"},{"key":"2022041109372108600_B279","doi-asserted-by":"publisher","first-page":"1016.e10","DOI":"10.1016\/j.neuron.2019.07.002","article-title":"Development of a chimeric model to study and manipulate human microglia in vivo","volume":"103","author":"Hasselmann","year":"2019","journal-title":"Neuron"},{"key":"2022041109372108600_B280","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.stem.2019.05.009","article-title":"Dosage counts: correcting Trisomy-21-related phenotypes in human organoids and xenografts","volume":"24","author":"Manley","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B281","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","article-title":"Stem-cell-derived human microglia transplanted in mouse brain to study human disease","volume":"22","author":"Mancuso","year":"2019","journal-title":"Nat. Neurosci."},{"key":"2022041109372108600_B282","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/90795","article-title":"Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice","volume":"19","author":"Saito","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"2022041109372108600_B283","doi-asserted-by":"publisher","first-page":"n1682","DOI":"10.1136\/bmj.n1682","article-title":"Aducanumab for Alzheimer\u2019s disease?","volume":"374","author":"Walsh","year":"2021","journal-title":"BMJ"},{"key":"2022041109372108600_B284","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1212\/WNL.0000000000012452","article-title":"Prescribing aducanumab in the face of meager efficacy and real risks","volume":"97","author":"Knopman","year":"2021","journal-title":"Neurology"},{"key":"2022041109372108600_B285","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nchembio0407-187","article-title":"What\u2019s wrong with drug screening today","volume":"3","author":"Nolan","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"2022041109372108600_B286","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1089\/scd.2014.0531","article-title":"Induced pluripotent stem cell models to enable in vitro models for screening in the central nervous system","volume":"24","author":"Hunsberger","year":"2015","journal-title":"Stem Cells Dev."},{"key":"2022041109372108600_B287","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ijms22031203","article-title":"Human iPSC-based modeling of central nerve system disorders for drug discovery","volume":"22","author":"Qian","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2022041109372108600_B288","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.celrep.2017.10.109","article-title":"iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid \u03b2 combination for Alzheimer\u2019s disease","volume":"21","author":"Kondo","year":"2017","journal-title":"Cell Rep."},{"key":"2022041109372108600_B289","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2022041109372108600_B290","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2217\/rme-2018-0095","article-title":"Quality control guidelines for clinical-grade human induced pluripotent stem cell lines","volume":"13","author":"Sullivan","year":"2018","journal-title":"Regen. Med."},{"key":"2022041109372108600_B291","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.stemcr.2018.08.013","article-title":"Reproducibility of molecular phenotypes after long-term differentiation to human iPSC-derived neurons: a multi-site omics study","volume":"11","author":"Volpato","year":"2018","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B292","doi-asserted-by":"publisher","first-page":"70","DOI":"10.7196\/SAMJ.2019.v109i8b.14009","article-title":"Stem cell therapy for neurological disorders","volume":"109","author":"Alessandrini","year":"2019","journal-title":"S. Afr. Med. J."},{"key":"2022041109372108600_B293","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-018-33017-6","article-title":"Human neural stem cell transplantation improves cognition in a murine model of Alzheimer\u2019s disease","volume":"8","author":"McGinley","year":"2018","journal-title":"Sci. Rep."},{"key":"2022041109372108600_B294","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nbt.2565","article-title":"Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits","volume":"31","author":"Liu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"2022041109372108600_B295","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/stem.626","article-title":"The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells","volume":"29","author":"Bissonnette","year":"2011","journal-title":"Stem Cells"},{"key":"2022041109372108600_B296","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.stemcr.2015.09.010","article-title":"ESC-derived basal forebrain cholinergic neurons ameliorate the cognitive symptoms associated with Alzheimer\u2019s disease in mouse models","volume":"5","author":"Yue","year":"2015","journal-title":"Stem Cell Rep."},{"key":"2022041109372108600_B297","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.stem.2016.07.015","article-title":"Global distribution of businesses marketing stem cell-based interventions","volume":"19","author":"Berger","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"3111","key":"2022041109372108600_B298","doi-asserted-by":"crossref","DOI":"10.1016\/S0262-4079(17)30199-9","article-title":"Clinic claims it has used stem cells to treat Down\u2019s syndrome","author":"Coghlan","year":"2017","journal-title":"New Scientist"},{"key":"2022041109372108600_B299","doi-asserted-by":"publisher","first-page":"123","DOI":"10.14740\/jmc2455w","article-title":"Human embryonic stem cells in the treatment of patients with Down Syndrome: a case report","volume":"2016","author":"Shroff","year":"2016","journal-title":"J. Med. Cases"},{"key":"2022041109372108600_B300","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FJC.0b013e318247f642","article-title":"Induced pluripotent stem cells as a disease modeling and drug screening platform","volume":"60","author":"Ebert","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2022041109372108600_B301","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021110002","article-title":"Do we still need animals? Surveying the role of animal-free models in Alzheimer\u2019s and Parkinson\u2019s disease research","volume":"e110002","author":"Aerts","year":"2022","journal-title":"EMBO J"},{"key":"2022041109372108600_B302","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s11064-018-2663-z","article-title":"Modelling sporadic Alzheimer\u2019s disease using induced pluripotent stem cells","volume":"43","author":"Rowland","year":"2018","journal-title":"Neurochem. Res."},{"key":"2022041109372108600_B303","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050403","article-title":"Current challenges of iPSC-based disease modeling and therapeutic implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"}],"container-title":["Neuronal Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/neuronalsignal\/article-pdf\/doi\/10.1042\/NS20210054\/931619\/ns-2021-0054c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/neuronalsignal\/article-pdf\/doi\/10.1042\/NS20210054\/931619\/ns-2021-0054c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T09:37:48Z","timestamp":1649669868000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/neuronalsignal\/article\/6\/1\/NS20210054\/231069\/Cell-models-for-Down-syndrome-Alzheimer-s-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":303,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,4,29]]}},"URL":"https:\/\/doi.org\/10.1042\/ns20210054","relation":{},"ISSN":["2059-6553"],"issn-type":[{"value":"2059-6553","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,4]]},"article-number":"NS20210054"}}